Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synovial Fluid Changes with Amniotic Tissue Allograft in Knee OA
NCT03408145Completed
- Sponsor
- Stone Research Foundation
- Start
- Jan 2018
- Primary completion
- Oct 2019
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Randomised, single-blind trial of PalinGen InovoFlo in osteoarthritis (OA) (4 arms), sponsored by Stone Research Foundation. Primary endpoint: Knee Joint Chemical Profile at 1 week. Started Jan 2018; status: completed.
02
Drugs
PalinGen InovoFlo
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03408145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03408145.